REG

Revenio Group

Stock
Stock
ISIN: FI0009010912
Ticker: REG1V
FI0009010912
REG1V

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

 


$0.282

CHART BY

Frequently asked questions

The market capitalization of Revenio Group is $401.95M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Revenio Group is 26.35. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Revenio Group's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.573. EPS indicates the company's profitability on a per-share basis.
Currently, 5 analysts cover Revenio Group's stock, with a consensus target price of $19.08. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Revenio Group reported a revenue of $143.54M.
Revenio Group's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $26.34M. EBITDA measures the company's overall financial performance.
Revenio Group has a free cash flow of $13.74M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Revenio Group employs approximately 247 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of Revenio Group is 20.01M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$401.95M
EPS (TTM) 
$0.573
Free Float 
20.01M
P/E ratio (TTM) 
26.35
Revenue (TTM) 
$143.54M
EBITDA (TTM) 
$26.34M
Free Cashflow (TTM) 
$13.74M

Pricing

1D span
$15.05$15.75
52W span
$13.50$29.90

Analyst Ratings

The price target is $19.08 and the stock is covered by 5 analysts.

Buy

4

Hold

1

Sell

0

Information

Revenio Group Oyj engages in ophthalmic diagnostics and the manufacture and sale of ophthalmic devices. The firm's ophthalmic diagnostic solutions include intraocular pressure measurement devices under the iCare brand, retinal imaging devices, and perimeters. It operates through the following geographical segments: Finland, Other Europe, North America, and Others. The company was founded in 2001 and is headquartered in Vantaa, Finland.

Employees
247
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
FI0009010912
Primary Ticker
REG1V

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation